StockNews.AI
APDN
StockNews.AI
64 days

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

1. APDN will resume regular quarterly investor calls starting August 2025. 2. The intra-quarter investor call on June 17, 2025, has been cancelled. 3. APDN focuses on PCR technologies for DNA production and detection. 4. They operate in synthetic DNA and molecular diagnostics markets.

Earnings
+1.07%Current Return
VS
+0.18%S&P 500
$4.67506/16 09:07 AM EDTEvent Start
$4.72506/17 03:34 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

The announcement of resuming calls is routine. Historical investor call patterns haven't significantly impacted stock price.

How important is it?

Regular communication is important but doesn't reveal new information affecting valuations.

Why Short Term?

Resuming investor calls may provide clarity temporarily but lacks long-term implications.

Related Companies

N/A
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mid-August 2025. In alignment with this resumption, the Company has cancelled its previously scheduled intra-quarter investor call for June 17, 2025.About Applied DNA SciencesApplied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.Visit adnas.com for more information. Follow us on X and LinkedIn.Applied DNA Sciences Contact:Investor Relations contact:Sanjay M. Hurry, 917-733-5573, [email protected]Web: https://investors.adnas.com/SOURCE: Applied DNA Sciences

Related News